Use of isoniazid chemoprophylaxis in renal transplant recipients

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 634-637

  Naqvi, Rubina ^a   Naqvi, Anwar ^a   Akhtar, Sohail ^a   Ahmed, Ejaz ^a   Noor, Huma ^a   Saeed, Tahir ^a   Akhtar, Fazal ^a   Rizvi, Adib ^a  

^a SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

Author keywords

Isoniazid; Kidney transplantation; Prophylaxis; Tuberculosis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; ISONIAZID; PREDNISOLONE;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; ISONIAZID; KIDNEY TRANSPLANTATION; MALE; PROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 75649144413     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp489     Document Type: Article

References (29)

1. Facts Sheet No 104, Tuberculosis. www.who.int (Revised March 2007) 2007.
2. Rao NA. Prevalence of pulmonary tuberculosis in Karachi Central Prison. J Pakistan Med Assoc 2004; 54: 413-415
3. Country Profile, Pakistan, Global TB control. WHO report 2003; 99-101
4. Naqvi A, Akhtar F, Naqvi R et al. Problems ofdiagnosis and treatment of tuberculosis following renal transplantation. Transplant Proc 1997; 29: 3051-3052
5. Naqvi A, Rizvi A, Hussain Z et al. Developing world perspective of post transplant tuberculosis: morbidity, mortality and cost implications. Transplant Proc 2001; 33: 1787-1788
6. Sayiner A, Ece T, Duman S et al. Tuberculosis in renal transplant recipients. Transplantation 1999; 68: 1268-1271
7. Fitzgerald DW, Desvarieux M, Severe P et al. Effect of post treatment isoniazid on prevention of recurrent tuberculosis in HIV-1 infected individuals: a randomized trial. Lancet 2000; 356: 1470-1474
8. El-Agroudy AE, Refaie AF, Moussa OM et al. Tuberculosis in Egyptian kidney transplantrecipients: studyof clinical course and outcome. J Nephrol 2003; 16: 404-411
9. John GT, Thomas PP, Thomas M et al. A double blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994; 57: 1683-1684
10. Agarwal SK, Gupta S, Dash SC et al. Prospective randomized trial of isoniazid prophylaxis in renal transplant recipients. Int Urol Nephrol 2004; 36: 425-431
11. Singh N, Wagener MM, Gayown T. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of post transplant tuberculosis. Transplantation 2002, 74: 892-895
12. Yildiz A, Sever MS, Turkmen A et al. Tuberculosis after renal transplantation: experience of one Turkish center. Nephrol Dial Transplant 1998; 13: 1872-1875
13. Lui SL, Li FK, Choy BY et al. Long term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients. Transpl Infect Dis 2004; 6: 55-56
14. Matuck TA, Brasil P, Alvarenga Mde F et al. Tuberculosis in renal transplants in Rio De Janeiro. Transplant Proc 2004; 36: 905-906
15. Koseiji M, Kandus A, Ales A et al. Mycobacterial infection in renal transplant recipients. Transplant Proc 2000; 32: 152-154
16. Melchor JL, Gracida C, Ibarra A. Increased frequency of tuberculosis in Mexican renal transplant recipients: a single center experience. Transplant Proc 2002; 34: 78-79
17. Vandermarliere A, Audenhove AV, Peetermans WE et al. Mycobac-terial infection after renal transplantation in a Western population. Transpl Infect Dis 2003; 5: 9-15
18. Hussein MM, Mooij JP, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial 2003; 16: 38-44
19. Queipo JA, Broseta E, Santos M et al. Mycobacterial infections in a series of 1261 renal transplant recipients. Clin Microbiol Infect 2003; 9: 518-525
20. Lattes R, Radisic M, Rial M et al. Tuberculosis in renal transplant recipients. Tranpl Infect Dis 1999; 1: 98-104
21. Armitage P and Berry G (eds). Statistical Methods in Medical Research, 3rd edn. Blackwell Scientific Publications, London, 1994, 572-575
22. Ioannidis JPA, Evan SJW, Gotzsche PC et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004; 141: 781-788
23. Gray DM, Zar H, Cotton M. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Cochrane Database Syst Rev 2009; Jan 21;(1) Art. No.: CD006418. DOI: 10.1002/14651858.CD006418.pub2.
24. Rieder HL, Watson JM, Raviglione MC et al. Surveillance of tuberculosis in Europe. Eur Respir J 1996; 9: 1097-1104
25. Jie T, Matas AJ, Gillingham KJ et al. Mycobacterial infections after kidney transplant. Transplant Proc 2005; 37: 937-939
26. Chugh KS, Jha V. Tuberculosis in organ transplant recipients. Transplant Proc 2003; 35: 2676-2677
27. Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infection. N Engl J Med 2002; 347: 1860-1866
28. European best practice guidelines for Renal Transplant 2. Nephrol Dial Transplant 2002; 17(Suppl IV): 39-43
29. Antony SJ, Ynares C, Dummer JS. Isoniazid hepatotoxicity in renal transplant recipients. Clin Transplant 1997; 11: 34-37